Guideline Adherence to Benign Paroxysmal Positional Vertigo Treatment and Management in Primary Care

Abstract

AbstractObjectiveTo determine adherence to the 2017 American Academy of Otolaryngology‐Head and Neck Surgery (AAO‐HNS) guidelines for the management and treatment of benign paroxysmal positional vertigo (BPPV) in primary care (PC) and compare whether key recommendations differed by sex, race, or insurance status.Study DesignRetrospective chart review.SettingTwenty‐six clinic locations within a single healthcare system.MethodsCharts of 458 patients diagnosed with BPPV in PC between 2018 and 2022 were reviewed. Encounters where the diagnosis of BPPV was made were identified. From the clinical encounter note, demographics, symptomatology, management, and treatment were extracted. Nonparametric analyses were used to identify whether AAO‐HNS guidelines differed regarding sex, race, or insurance status.ResultsOf 458 patients, 249 (54.4%) did not receive a diagnostic exam, and only 4 (0.9%) patients received imaging. Regarding treatment, only 51 (11.1%) received the Epley maneuver, with 263 (57.4%) receiving vestibular suppressant medication and 12.4% receiving a referral to a specialist. In regard to sex, race, or insurance status, there was no significant difference in receiving a Dix‐Hallpike diagnostic maneuver, Epley maneuver, vestibular suppressant medication, imaging, or referral to a specialist.ConclusionOur data suggest that there continue to be gaps in the adherence to AAO‐HNS guidelines; however, these gaps did not differ by sex, race, or insurance status. Care should be taken to increase the use of diagnostic and treatment maneuvers but decrease the use of vestibular‐suppressant medications for the treatment of BPPV in PC.